AmacaThera, a leading biotechnology company specialising in next-generation hydrogel-based drug delivery systems, has entered into an exclusive global licensing agreement with Pacira BioSciences, Inc., a leader in non-opioid pain management, to develop and commercialise AMT-143.
Pacira BioSciences | 05/11/2025 | By Darshana
Johnson and Johnson to Co-Promote ZILRETTA with Pacira BioSciences
Johnson and Johnson MedTech and Pacira BioSciences have announced a strategic collaboration to expand the market reach of ZILRETTA - Pacira’s extended-release treatment for osteoarthritis knee pain.
Pacira BioSciences | 22/07/2025 | By Dineshwori | 284
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy